Condition: Severe Mitral Regurgitation · Sponsor: Insel Gruppe AG, University Hospital Bern
The investigators' hypothesis is that CMR tissue characterization and myocardial function analysis acquired by CMR feature tracking technique predict reverse remodeling in patients with severe secondary mitral regurgitation (MR) undergoing transcatheter mitral edge-to-edge repair.
This description comes directly from the study's public registry record.
Christoph MD Gräni, PHD · +41 31 632 4508 · christoph.graeni@insel.ch
Always discuss trial participation with your own doctor first.
| Department of Cardiology, University Hospital Bern, Inselspital, Bern | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04913727